Key Developments: Pain Therapeutics Inc (PTIE.O)
31 Mar 2015
Latest Key Developments (Source: Significant Developments)
Pfizer Inc:To discontinue its agreement to develop and commercialize REMOXY (oxycodone) Extended-Release Capsules CII, an investigational extended-release oral formulation of oxycodone.To return all rights, including responsibility for regulatory activities, to Pain Therapeutics, Inc. Full Article
- Pfizer Inc ended an agreement with Pain Therapeutics Inc to develop and market Durect Corp's pain drug, Remoxy, sending the stocks of the two smaller drugmakers plummeting.